Clavaspirins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530323, 530326, 530332, C07K 14435, A61K 3817

Patent

active

059983744

ABSTRACT:
Novel microbial peptides called clavaspirins are of the formula (SEQ ID NO:1)

REFERENCES:
Bensch, K.W. et al. FEBS Lett (1995) 368:331.
Christensen, B. et al. Proc Natl Acad Sci USA (1988) 85:5072.
Cornelissen, B.J.C. et al. Plant Physiol (1993) 101:709-712.
Diamond, G. et al. Proc Natl Acad Sci USA (1991) 88:3952.
Duclohier, H. et al. Biophys J (1989) 56:1017.
Harwig, S.S.L. et al. FEBS Lett (1994) 342:281.
Jones, D.E. et al. J. Biol Chem (1992) 267:23216.
Kokryakov, V.N. et al. FEBS Lett (1993) 231.
Lehrer, R.I. et al. Ann Rev Immunol (1992) 11:105.
Nakamura, T. et al., J Biol Chem (1988) 263:16709-16713.
Patterson-Delafield, J. et al. Infect Immun (1980) 30:180.
Schonwetter, B.S. et al. Science (1995) 267:1645.
Selsted, M.E. et al. J. Biol Chem (1993) 268:6641.
Terry, A.S. et al. J Biol Chem (1988) 263:5745.
Zasloff, M. Proc Natl Acad Sci USA (1987) 84:5449.
Zasloff, M. Proc Natl Acad Sci USA (1988) 85:910.
I.H. Lee et al., "Clavanins, Alpha-Helical Antimicrobial Peptides From Tunicate Hemocytes", FEBS Letts. 400(2): 158-162, Jan. 1997.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Clavaspirins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Clavaspirins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clavaspirins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-823800

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.